UNLIMITED FREE
ACCESS
TO THE WORLD'S BEST IDEAS

SUBMIT
Already a GlobalSpec user? Log in.

This is embarrasing...

An error occurred while processing the form. Please try again in a few minutes.

Customize Your GlobalSpec Experience

Finish!
Privacy Policy

This is embarrasing...

An error occurred while processing the form. Please try again in a few minutes.

CLSI I/LA28

Quality Assurance for Design Control and Implementation of Immunohistochemistry Assays; Approved Guideline

inactive
Buy Now
Organization: CLSI
Publication Date: 1 January 2011
Status: inactive
Page Count: 156
scope:

The purpose of this document is to provide guidance to all of the stakeholders involved with design and implementation of immunohistochemistry (IHC) assays. It is intended for use by all clinical and reference laboratories performing immunocytochemical assays on cytological preparations or immunohistochemical assays on surgical pathology specimens, for the manufacturers of commercial reagents and test kits, and for individuals and organizations involved in the development and implementation of laboratory quality assurance (QA) programs for these assays

The purpose of this document is to provide guidance to all of the stakeholders involved with design and implementation of immunohistochemistry (IHC) assays. It is intended for use by all clinical and reference laboratories performing immunocytochemical assays on cytological preparations or immunohistochemical assays on surgical pathology specimens, for the manufacturers of commercial reagents and test kits, and for individuals and organizations involved in the development and implementation of laboratory quality assurance (QA) programs for these assays

Document History

January 1, 2011
Quality Assurance for Design Control and Implementation of Immunohistochemistry Assays; Approved Guideline
The purpose of this document is to provide guidance to all of the stakeholders involved with design and implementation of immunohistochemistry (IHC) assays. It is intended for use by all clinical and...
CLSI I/LA28
January 1, 2011
Quality Assurance for Design Control and Implementation of Immunohistochemistry Assays; Approved Guideline
The purpose of this document is to provide guidance to all of the stakeholders involved with design and implementation of immunohistochemistry (IHC) assays. It is intended for use by all clinical and...

References

Advertisement